ENDRA Life Sciences, Inc. (NDRA)
5.89
-0.02
(-0.25%)
USD |
NASDAQ |
Sep 09, 16:00
5.89
0.00 (0.00%)
After-Hours: 18:10
ENDRA Life Sciences Enterprise Value : 3.746M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.746M |
| September 04, 2026 | 3.963M |
| September 03, 2026 | 3.408M |
| September 02, 2026 | 4.578M |
| September 01, 2026 | 2.793M |
| August 31, 2026 | 2.396M |
| August 28, 2026 | 2.396M |
| August 27, 2026 | 2.996M |
| August 26, 2026 | 3.048M |
| August 25, 2026 | 2.013M |
| August 24, 2026 | 1.728M |
| August 21, 2026 | 1.624M |
| August 20, 2026 | 1.766M |
| August 19, 2026 | 1.668M |
| August 18, 2026 | 1.654M |
| August 17, 2026 | 1.624M |
| August 14, 2026 | 1.594M |
| August 13, 2026 | 1.594M |
| August 12, 2026 | 1.594M |
| August 11, 2026 | 1.504M |
| August 10, 2026 | 1.548M |
| August 07, 2026 | 1.788M |
| August 06, 2026 | 1.751M |
| August 05, 2026 | 1.698M |
| August 04, 2026 | 1.219M |
| Date | Value |
|---|---|
| August 03, 2026 | 1.159M |
| July 31, 2026 | 1.938M |
| July 30, 2026 | 1.384M |
| July 29, 2026 | 1.564M |
| July 28, 2026 | 1.578M |
| July 27, 2026 | 2.058M |
| July 24, 2026 | 2.178M |
| July 23, 2026 | 2.733M |
| July 22, 2026 | 3.303M |
| July 21, 2026 | 2.928M |
| July 20, 2026 | 2.306M |
| July 17, 2026 | 2.373M |
| July 16, 2026 | 2.793M |
| July 15, 2026 | 3.303M |
| July 14, 2026 | 3.198M |
| July 13, 2026 | 3.138M |
| July 10, 2026 | 3.303M |
| July 09, 2026 | 3.123M |
| July 08, 2026 | 2.028M |
| July 07, 2026 | 2.313M |
| July 06, 2026 | 2.073M |
| July 02, 2026 | 1.968M |
| July 01, 2026 | 2.448M |
| June 30, 2026 | 2.883M |
| June 29, 2026 | 6.309M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 177.77M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 530.17M |
| ResMed, Inc. | 31.24B |
| Rockwell Medical, Inc. | 21.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.1599M |
| Total Expenses (Quarterly) | -0.1599M |
| EPS Diluted (Quarterly) | 0.1208 |
| Earnings Yield | -107.3% |
| Normalized Earnings Yield | -103.48 |